420 with CNW — Why Marijuana’s $100 Billion Economic Impact Varies by State
The recreational and medical marijuana markets continue to have a positive economic impact on the nation as a whole. However, the effects on individual states vary according to the size, maturity and nature of each market. Compared to certain larger, highly populated states with larger markets, some smaller, less populous states are seeing a stronger overall impact on the economy.
Statistics from the just-released MJBizFactbook indicate that the total economic impact of cannabis sales in the United States is predicted to hit $100 billion this year, a rise of more than 12% from 2022. Marijuana sales could inject $17.6 billion this year into California’s economy—the largest marijuana market in terms of population and sales. Conversely, cannabis contributes significantly less to the thinly populated medical and recreational markets. For example, Mississippi, which opened sales in January, is predicted to see a $30 million increase in revenue by year’s end.
When the population of a state is taken into consideration, certain people benefit more than others. Although the California marijuana sector might have the greatest total impact, other jurisdictions offer more impact per individual. For instance, the cannabis market in Alaska is poised to create an average economic contribution to each individual this year of about $1,431. The marijuana industries in Massachusetts, Colorado, Michigan, New Mexico, Nevada and Montana will each contribute nearly $800 per citizen. California, on the other hand, with roughly three times the revenue of Colorado, will only contribute around $450 in economic benefit per person.
Economic influence occurs in both indirect and direct ways. Workers in the marijuana sector can use their earnings to pay for basic needs such as food, shelter, transportation and other essentials. Additionally, cannabis companies, patients and customers shell out millions in local and state taxes, which are used to fund infrastructure improvements such as roads and schools. Real estate businesses also benefit from the opening and expansion of the manufacturing, retail and agricultural industries, which raises demand for properties.
Contrary to supply-chain income, which is commonly used to estimate a sector’s overall size, the economic impact of the cannabis industry is distinct from that of other industries. For cannabis, the multiplier demonstrates how the industry influences the whole economy.
In this event, every $1 that patients and customers spend in retail outlets, a substantial amount of it locally, injects an additional $2 into the economy. While the multiplier approach isn’t ideal for local effect studies, it still offers a great projection of how cannabis affects the economy as a whole.
It would be interesting to learn how the economic benefits arising from companies such as IGC Pharma Inc. (NYSE American: IGC) can be computed, given that the cannabis-based medicines that they are developing can be used across the nation and globally once they receive FDA or regulatory approval.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
The recreational and medical marijuana markets continue to have a positive economic impact on the nation as a whole. However, the effects on individual states vary according to the size, maturity and nature of each market. Compared to certain larger, highly populated states with larger markets, some smaller, less populous states are seeing a stronger overall impact on the economy.
Statistics from the just-released MJBizFactbook indicate that the total economic impact of cannabis sales in the United States is predicted to hit $100 billion this year, a rise of more than 12% from 2022. Marijuana sales could inject $17.6 billion this year into California’s economy—the largest marijuana market in terms of population and sales. Conversely, cannabis contributes significantly less to the thinly populated medical and recreational markets. For example, Mississippi, which opened sales in January, is predicted to see a $30 million increase in revenue by year’s end.
When the population of a state is taken into consideration, certain people benefit more than others. Although the California marijuana sector might have the greatest total impact, other jurisdictions offer more impact per individual. For instance, the cannabis market in Alaska is poised to create an average economic contribution to each individual this year of about $1,431. The marijuana industries in Massachusetts, Colorado, Michigan, New Mexico, Nevada and Montana will each contribute nearly $800 per citizen. California, on the other hand, with roughly three times the revenue of Colorado, will only contribute around $450 in economic benefit per person.
Economic influence occurs in both indirect and direct ways. Workers in the marijuana sector can use their earnings to pay for basic needs such as food, shelter, transportation and other essentials. Additionally, cannabis companies, patients and customers shell out millions in local and state taxes, which are used to fund infrastructure improvements such as roads and schools. Real estate businesses also benefit from the opening and expansion of the manufacturing, retail and agricultural industries, which raises demand for properties.
Contrary to supply-chain income, which is commonly used to estimate a sector’s overall size, the economic impact of the cannabis industry is distinct from that of other industries. For cannabis, the multiplier demonstrates how the industry influences the whole economy.
In this event, every $1 that patients and customers spend in retail outlets, a substantial amount of it locally, injects an additional $2 into the economy. While the multiplier approach isn’t ideal for local effect studies, it still offers a great projection of how cannabis affects the economy as a whole.
It would be interesting to learn how the economic benefits arising from companies such as IGC Pharma Inc. (NYSE American: IGC) can be computed, given that the cannabis-based medicines that they are developing can be used across the nation and globally once they receive FDA or regulatory approval.
NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
